Clicky

Össur hf(OSSFF)

Description: Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers prosthetics products, including artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, fingers, liners, and other components. The company also provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.


Keywords: Medicine Surgery Healthcare Providers Orthopedic Surgery Surgical Specialties Prosthesis Soft Tissue Injuries Amputation Direct Sales Networks Injury Solutions Non Invasive Orthopedic Products Prosthetics Products össur

Home Page: www.emblamedical.com

GrjOthAls 1-5
Reykjavik,
Iceland
Phone: 354 515 1300


Officers

Name Title
Mr. Sveinn Solvason President & CEO
Mr. Ossur Kristinsson Founder
Ms. Gudny Arna Sveinsdottir Chief Financial Officer
Mr. Lukas Marklin Chief Operating Officer
Edda Lara Luovigsdottir Investor Relations Director
Ms. Margret Lara Fridriksdottir Executive Vice President of People, Strategy & Sustainability
Mr. Olafur Gylfason Executive Vice President of Chronic Solutions
Mr. Christian Robinson President of Americas
Ms. Hildur Einarsdottir Executive Vice President of Research & Development

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 32.3438
Price-to-Book MRQ: 2.8186
Price-to-Sales TTM: 2.6891
IPO Date:
Fiscal Year End: December
Full Time Employees: 4000
Back to stocks